PG Add to watchlist
$143.11 +0.00 (+0.00%)
Pre-Market: $146.93 +3.82 (+2.67%)
Last updated: Apr 20, 2026 13:07
52-Week Range
$146.93
$137.62 $146.93 $170.99

Fundamentals Overview

The Procter & Gamble Company is in the middle of its 52-week range with premium valuation, trending upward today.

Valuation premium

P/E 21.6 PEG 3.4 P/B 6.68 P/S 4.03

Intrinsic value (DCF)

+61.4% upside vs price

Profitability

Net margin 19.3%

Risk (Beta)

0.4 — lower vol

Earnings & growth

EPS $6.79 Rev -0.8% Profit -8.8% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Buy — 68% confidence Risk: Lower Volatility — Beta 0.4. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +61.4% upside vs price · Analyst grade: B+

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$343.34B
P/E (TTM)
21.63
EPS (TTM)
$6.79
Dividend Yield
1.44%
52-Week Range
$137.62 - $170.99
Volume vs Avg
N/A
Beta
0.4

About

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The...
Sector: Consumer Defensive
Headquarters: US
Employees: 108,000
IPO Date: Jan 1978
Website: us.pg.com
Beta: 0.4 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: mixed. Current institutional positions: Buy: 9, Equal Weight: 4, Hold: 3, Neutral: 5, Outperform: 2, Overweight: 7.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $237.11; current price is $146.93. That’s a +61.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 21.63
DCF value (model) $237.11 (61.4% upside)
PEG (TTM) 3.4
P/B (TTM) 6.68
P/S (TTM) 4.03
P/FCF (TTM) 23.12
Liquidity & enterprise
Current Ratio (TTM) 0.72
Quick Ratio (TTM) 0.51
Cash Ratio (TTM) 0.29
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 19.31%
Gross margin (TTM) 50.68%
Operating margin (TTM) 23.62%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for PG.

Analyst Sentiment at a Glance

B+ Sentiment Mixed
Buy 9Equal Weight 4Hold 3Neutral 5Outperform 2Overweight 7
2 upgrades, 2 downgrades
Price Target Consensus
Current $146.93
Median $170.00
Consensus $165.14
Low consensus $142.00
High consensus $179.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
JP Morgan maintain Overweight Overweight 2026-04-17
Barclays maintain Equal Weight Equal Weight 2026-04-14
B of A Securities maintain Buy Buy 2026-04-10
Piper Sandler maintain Neutral Neutral 2026-04-08
Wells Fargo maintain Overweight Overweight 2026-04-08
UBS maintain Buy Buy 2026-04-07
Deutsche Bank maintain Hold Hold 2026-03-30
TD Cowen downgrade Buy Hold 2026-01-27
JP Morgan upgrade Neutral Overweight 2026-01-23
UBS maintain Buy Buy 2026-01-23
Wells Fargo maintain Overweight Overweight 2026-01-23
UBS maintain Buy Buy 2026-01-14
TD Cowen maintain Buy Buy 2026-01-08
Wells Fargo maintain Overweight Overweight 2026-01-05
JP Morgan maintain Neutral Neutral 2025-12-18
Jefferies upgrade Hold Buy 2025-12-17
Freedom Broker maintain Hold Hold 2025-10-29
JP Morgan maintain Neutral Neutral 2025-10-27
Raymond James maintain Outperform Outperform 2025-10-20
JP Morgan maintain Neutral Neutral 2025-10-10
UBS maintain Buy Buy 2025-10-08
B of A Securities maintain Buy Buy 2025-10-08
Barclays maintain Equal Weight Equal Weight 2025-10-01
Wells Fargo maintain Overweight Overweight 2025-09-25
BNP Paribas maintain Outperform Outperform 2025-08-15
Barclays maintain Equal Weight Equal Weight 2025-07-31
Wells Fargo maintain Overweight Overweight 2025-07-30
JP Morgan downgrade Overweight Neutral 2025-07-25
UBS maintain Buy Buy 2025-07-17
Barclays maintain Equal Weight Equal Weight 2025-07-15